150 related articles for article (PubMed ID: 21466053)
1. The value of proton MR-spectroscopy in the differentiation of brain tumours from non-neoplastic brain lesions.
Aydin H; Sipahioğlu S; Oktay NA; Altin E; Kizilgöz V; Hekimoglu B
JBR-BTR; 2011; 94(1):1-10. PubMed ID: 21466053
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
Zeng Q; Liu H; Zhang K; Li C; Zhou G
Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification.
Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S
Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519
[TBL] [Abstract][Full Text] [Related]
4. 1H MR spectroscopy in the assessment of gliomatosis cerebri.
Guzmán-de-Villoria JA; Sánchez-González J; Muñoz L; Reig S; Benito C; García-Barreno P; Desco M
AJR Am J Roentgenol; 2007 Mar; 188(3):710-4. PubMed ID: 17312058
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].
Ando K; Ishikura R; Nagami Y; Morikawa T; Takada Y; Ikeda J; Nakao N; Matsumoto T; Arita N
Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Mar; 64(3):121-6. PubMed ID: 15148787
[TBL] [Abstract][Full Text] [Related]
6. Brain tumors: localized H-1 MR spectroscopy at 0.5 T.
Prost R; Haughton V; Li SJ
Radiology; 1997 Jul; 204(1):235-8. PubMed ID: 9205253
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
8. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
9. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
11. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
[TBL] [Abstract][Full Text] [Related]
13. In vivo proton spectroscopy of giant cell tumor of the bone.
Sah PL; Sharma R; Kandpal H; Seith A; Rastogi S; Bandhu S; Jagannathan NR
AJR Am J Roentgenol; 2008 Feb; 190(2):W133-9. PubMed ID: 18212197
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
15. Comments and controversies: magnetic resonance spectroscopy and gliomas.
Fan G
Cancer Imaging; 2006 Sep; 6(1):113-5. PubMed ID: 16966066
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases.
Chawla S; Zhang Y; Wang S; Chaudhary S; Chou C; O'Rourke DM; Vossough A; Melhem ER; Poptani H
J Comput Assist Tomogr; 2010; 34(6):836-41. PubMed ID: 21084897
[TBL] [Abstract][Full Text] [Related]
17. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
Alimenti A; Delavelle J; Lazeyras F; Yilmaz H; Dietrich PY; de Tribolet N; Lövblad KO
Eur Neurol; 2007; 58(4):198-209. PubMed ID: 17823533
[TBL] [Abstract][Full Text] [Related]
18. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
19. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
20. 1H MR spectroscopy of brain tumours and masses.
Howe FA; Opstad KS
NMR Biomed; 2003 May; 16(3):123-31. PubMed ID: 12884355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]